Scodari Joseph C has filed 5 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 2150 shares of Acurx Pharmaceuticals, Inc. ($ACXP) on April 20, 2026.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 20, 2026 | Acurx Pharmaceuticals, Inc. | $ACXP | Scodari Joseph C | Director | A | Stock Option | 2150 | $0.00 | 2,150.0000 | 1,498,793 | 9999.99% | 0.14% |
| Jan. 6, 2025 | Acurx Pharmaceuticals, Inc. | $ACXP | Scodari Joseph C | Director | P | Common Stock | 24631 | $1.02 | 27,708.0000 | 16,163,366 | 800.49% | 0.15% |
| Jan. 6, 2025 | Acurx Pharmaceuticals, Inc. | $ACXP | Scodari Joseph C | Director | P | Warrants for Common Stock | 24631 | $0.00 | 24,631.0000 | 16,163,366 | 9999.99% | 0.15% |
| June 17, 2024 | Acurx Pharmaceuticals, Inc. | $ACXP | Scodari Joseph C | Director | A | Stock Option | 12000 | $0.00 | 12,000.0000 | 15,472,507 | 9999.99% | 0.08% |
| June 15, 2023 | Acurx Pharmaceuticals, Inc. | $ACXP | Scodari Joseph C | Director | A | Stock Option | 10000 | $0.00 | 10,000.0000 | 11,639,395 | 9999.99% | 0.09% |